Targeting GRP78 to enhance melanoma cell death
Version of Record online: 14 JUN 2010
© 2010 John Wiley & Sons A/S
Pigment Cell & Melanoma Research
Volume 23, Issue 5, pages 675–682, October 2010
How to Cite
Martin, S., Hill, D. S., Paton, J. C., Paton, A. W., Birch-Machin, M. A., Lovat, P. E. and Redfern, C. P.F. (2010), Targeting GRP78 to enhance melanoma cell death. Pigment Cell & Melanoma Research, 23: 675–682. doi: 10.1111/j.1755-148X.2010.00731.x
- Issue online: 1 SEP 2010
- Version of Record online: 14 JUN 2010
- PUBLICATION DATA Received 19 April 2010, revised and accepted for publication 2 June 2010, published online 14 June 2010
Figure S1. The effect of the GRP78-specific cytotoxin AB5 subtilase on apoptosis and viable cell number of CHL-1 and WM266-4 melanoma cultures.
Figure S2. Effect of GRP78 specific SB5 subtilase cytotoxin on the viability (number of viable cells) of CHL-1 (A, B) and WM266-4 (C, D) melanoma cells treated with fenretinide or bortezomib.
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
|PCMR_731_sm_FigsS1-S2.doc||1052K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.